Skip to content
lifestyle.cfxmagazine.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Anixa Biosciences, Inc.
Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium
June 11, 2026
Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
June 1, 2026
/C O R R E C T I O N — Anixa Biosciences, Inc./
May 21, 2026
Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
May 21, 2026
Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
May 1, 2026
Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
April 29, 2026
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
April 22, 2026
Anixa Biosciences to Participate in RedChip’s Biotech Resurgence: Platforms and Pipelines of Today’s Innovators Conference on April 16, 2026
April 9, 2026
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
April 7, 2026
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
April 6, 2026
1
2
3
Next Page
→